(1) Diseases or conditions listed in subsection (3), below, are identified by the Department as being of public health significance. These diseases or conditions must be reported by the practitioner, hospital, laboratory, or other individuals via telephone (with subsequent written report within 72 hours, see Rules 64D-3.030-.033, F.A.C.), facsimile, electronic data transfer, or other confidential means to the Department, which includes the County Health Departments. Reporters are not prohibited from reporting diseases or conditions not listed by rule. Reports should include all associated testing results performed (e.g. serogroup, serotype, and antimicrobial susceptibility results). Physicians and other healthcare providers using point of care tests for diagnosis of infectious diseases must report test results to the Department when they are indicative of an infectious disease reportable directly to the Department by laboratories unless such point of care testing is subject to routine reflex testing by a supplementary or confirmatory testing the results of which would be reportable.
    (2) Definitions to be used with subsection (3), below:
    (a) “”Reportable Diseases or Conditions”” – The definitions of “”suspected case”” and “”confirmed case”” for reportable diseases or conditions are set forth in “”Surveillance Case Definitions for Select Reportable Diseases in Florida,”” January 2016 version 1.1, incorporated by reference, available online at: https://www.flrules.org/Gateway/reference.asp?No=Ref-07442.
    (b) “”Suspect Immediately”” – A reportable condition of urgent public health importance. Report without delay upon the occurrence of any of the following: initial suspicion, receipt of a specimen with an accompanying request for an indicative or confirmatory test, findings indicative thereof, or suspected diagnosis. Reports that cannot timely be made during the County Health Department business day shall be made to the County Health Department after-hours duty official. If unable to do so, the reporter shall contact the Department after-hours duty official at (850)245-4401.
    (c) “”Immediately”” – A reportable condition of urgent public health importance. Report without delay upon the occurrence of any of the following: an indicative or confirmatory test, findings indicative thereof, or diagnosis. Reports that cannot timely be made during the County Health Department business day shall be made to the County Health Department after-hours duty official. If unable to do so, the reporter shall contact the Department after-hours duty official at (850)245-4401.
    (d) “”Next Business Day”” – Report before the closure of the County Health Department’s next business day following suspicion or diagnosis.
    (e) “”Other”” – Report consistent with the instruction in and footnotes to subsection (3), below.
    (3) “”Table of Reportable Diseases or Conditions to Be Reported””
Practitioner Reporting
Laboratory Reporting
Reportable Diseases or Conditions
Timeframes
Evidence of current or recent infection with etiological agents and all associated testing results performed should be reported (e.g. species, serogroup, serotype, and antimicrobial susceptibility *2 results)
Timeframes

Suspect Immediately
Immediately
Next Business Day
Other

Submit isolates or specimens for confirmation *1
Suspect Immediately
Immediately
Next Business Day
Other
Any case, cluster of cases, outbreak, or exposure to an infectious or non-infectious disease, condition, or agent found in the general community or any defined setting such as a hospital, school or other institution, not listed in this rule that is of urgent public health significance. This includes human cases, clusters, or outbreaks spread person-to-person, by animals or vectors or from an environmental, food or waterborne source of exposure; those that result from a deliberate act of terrorism; and unexplained deaths possibly due to unidentified infectious or chemical causes.

X
X

Detection in one or more specimens of etiological agents of a disease or condition not listed in this rule that is of urgent public health significance. This includes the identification of etiological agents that are suspected to be the cause of clusters, or outbreaks spread person-to-person, by animals or vectors or from an environmental, food, or waterborne source of exposure; those that result from a deliberate act of terrorism; and unexplained deaths due to unidentified infectious or chemical causes.

X
X

Acquired Immune
Deficiency Syndrome (AIDS)

2 weeks
Acquired Immune
Deficiency Syndrome (AIDS)
Laboratory Reporting Not Applicable
Amebic Encephalitis

X

Naegleria fowleri, Balamuthia mandrillaris, or Acanthamoeba species

X

Anthrax
X
X

Bacillus anthracis
X
X
X

Antimicrobial resistance surveillance
Practitioner Reporting Not Applicable
Antimicrobial resistance surveillance (for organisms not otherwise listed in this table), Acinetobacter baumannii, Citrobacter species, Enterococcus species, Enterobacter species, Escherichia coli species, Klebsiella species, Pseudomonas aeruginosa, Serratia species, isolated from a normally sterile site *3

X

Arsenic Poisoning *4a

X

Laboratory results as specified in the surveillance case definition *4a

X

Arboviral infections, not otherwise listed in this table (disease due to) *5
X

Including but not limited to: Flaviviridae, Togaviridae (e.g. chikungunya, Western equine encephalitis), Bunyaviridae (e.g. Heartland, Rift Valley Fever) *5
X
X

Babesiosis

X

Babesia spp.
X

X

Botulism, foodborne, other (includes wound and unspecified)
X
X

Clostridium botulinum or botulinum toxin
X
X
X

Botulism, infant

X

Clostridium botulinum or botulinum toxin
X

X

Brucellosis
X
X

Brucella species
X
X
X

California serogroup viruses (disease due to)

X

California serogroup viruses such as Jamestown Canyon, Keystone, and Lacrosse
X

X

Campylobacteriosis *4b

X

Campylobacter species *4b

X

Cancer (except non-melanoma skin cancer, and including benign and borderline intracranial and CNS tumors) *6

6 months
Pathological or tissue diagnosis of cancer (except non-melanoma skin cancer and including benign and borderline intracranial and CNS tumors)

6 months
Carbon monoxide poisoning

X

A volume fraction ≥ 0.09 (9%) of carboxyhemoglobin in blood

X

CD-4 absolute count and percentage of total lymphocytes
Practitioner Reporting Not Applicable
CD-4 absolute count and percentage of total lymphocytes *7

3 days
Chancroid

X

Haemophilus ducreyi

X

Chlamydia *8

X

Chlamydia trachomatis

X

Cholera
X
X

Vibrio cholerae
X

X

Ciguatera fish poisoning

X

Ciguatera fish poisoning
Laboratory Reporting Not Applicable
Congenital anomalies *9

6 months
Congenital anomalies
Laboratory tests as specified in Fl. Admin. Code R. 64D-3.035
Conjunctivitis in neonates < 14 days old X Conjunctivitis in neonates < 14 days old Laboratory Reporting Not Applicable Coronavirus (COVID 19) *23 X Coronavirus (COVID 19) *23 X Creutzfeld-Jakob disease (CJD) *10 X 14-3-3 or tau protein detection in CSF or immunohistochemical test or any brain pathology suggestive of CJD *10 X Cryptosporidiosis *4b X Cryptosporidium species *4b X Cyclosporiasis X Cyclospora cayetanensis X X Dengue *5 X Dengue virus *5 X X Diphtheria X X Corynebacterium diphtheriae X X X Eastern equine encephalitis X Eastern equine encephalitis virus X X Ehrlichiosis/Anaplasmosis X Anaplasma species or Ehrlichia species X X Escherichia coli Shiga toxin-producing (disease due to) *4b X Escherichia coli Shiga toxin-producing *4b X X Giardiasis (acute) *4b X Giardia species *4b X Glanders X X Burkholderia mallei X X X Gonorrhea *8 X Neisseria gonorrhoeae X Granuloma inguinale X Calymmatobacterium granulomatis X Haemophilus influenzae, meningitis and invasive disease, in children < 5 years old X X Haemophilus influenzae, all ages, isolated from a normally sterile site *11 X X X Hansen disease (Leprosy) X Mycobacterium leprae X Hantavirus infection X Hantavirus X X Hemolytic uremic syndrome X Not Applicable Hepatitis A *4b, 12 X Hepatitis A*4b, 12 X Hepatitis B, C, D, E and G *12 X Hepatitis B, C, D, E and G Virus *12 X Hepatitis B surface antigen (HBsAg)-positive in a pregnant woman or a child up to 24 months old X Hepatitis B surface antigen (HBsAg) X Herpes B virus, possible exposure X Herpes B virus, possible exposure Laboratory Reporting Not Applicable Herpes simplex virus (HSV) in infants up to 60 days old with disseminated infection with involvement of liver, encephalitis and infections limited to skin, eyes and mouth *13 X HSV 1 or HSV 2 by direct FA, PCR, DNA or Culture *13 X HSV - anogenital in children < 12 years of age *8, 13 X HSV 1 or HSV 2 by direct FA, PCR, DNA or Culture *13 X Human immunodeficiency virus (HIV) infection 2 weeks Repeatedly reactive enzyme immunoassay, followed by a positive confirmatory tests, (e.g. Western Blot, IFA): Positive result on any HIV virologic test (e.g. p24 AG, Nucleic Acid Test (NAT/NAAT) or viral culture). All viral load (detectable and undetectable) test results.*14, 15 3 days Human immunodeficiency virus (HIV) Exposed Newborn - infant < 18 months of age born to a HIV infected woman X All HIV test results (e.g., positive or negative immunoassay, positive or negative virologic tests) for those < 18 months of age 3 days Human papillomavirus (HPV) associated laryngeal papillomas or recurrent respiratory papillomatosis in children < 6 years of age *8 X HPV DNA X Human papillomavirus (HPV) - anogenital papillomas in children < 12 years of age *8 X HPV DNA X Human papillomavirus (HPV) Practitioner Reporting Not Applicable HPV DNA *3 X Influenza due to novel or pandemic strains X X Isolation of influenza virus from humans of a novel or pandemic strain X X X Influenza-associated pediatric mortality in persons aged < 18 years X Influenza virus - associated pediatric mortality in persons aged < 18 years (if known) X X Influenza Practitioner Reporting Not Applicable Influenza virus, all test results (positive and negative) *3 X Lead poisoning *4, 16 X All blood lead test results (positive and negative) *3, 4, 16 X Legionellosis X Legionella species X Leptospirosis X Leptospira species X Listeriosis X Listeria monocytogenes X X Lyme disease X Borrelia burgdorferi X Lymphogranuloma Venereum (LGV) X Chlamydia trachomatis X Malaria X Plasmodium species X X Measles (Rubeola) X X Measles virus *16 X X X Melioidosis X X Burkholderia pseudomallei X X X Meningitis, bacterial or mycotic X Isolation or demonstration of any bacterial or fungal species in cerebrospinal fluid X Meningococcal disease X X Neisseria meningitidis X X Mercury poisoning *4a X Laboratory results as specified in the surveillance case definition *4a X Mumps X Mumps virus X Neonatal Abstinence Syndrome *18 6 months Neonatal Abstinence Syndrome Laboratory Reporting Not Applicable Neurotoxic shellfish poisoning X Laboratory results as specified in the surveillance case definition *4a X Pertussis X Bordetella pertussis X Pesticide-related illness and injury *4 X Laboratory results as specified in the surveillance case definition *4 X Plague X X Yersinia pestis X X X Poliomyelitis X X Poliovirus X X X Psittacosis (Ornithosis) X Chlamydophila psittaci X X Q Fever X Coxiella burnetii X X Rabies, animal or human X Rabies virus X X Rabies, possible exposure *19 X X Rabies, possible exposure Laboratory Reporting Not Applicable Respiratory syncytial virus Practitioner Reporting Not Applicable Respiratory syncytial virus, all test results (positive and negative) *3 X Ricin toxicity X X Ricinine (from Ricinus communis castor beans) X X X Rocky Mountain spotted fever and other Spotted Fever Rickettsioses X Rickettsia rickettsii and other Spotted Fever Rickettsia species X X Rubella, including congenital X X Rubella virus *17 X X X St. Louis encephalitis (SLE) X St. Louis encephalitis virus X X Salmonellosis *4b X Salmonella species *4b X X Saxitoxin poisoning including Paralytic shellfish poisoning (PSP) X Saxitoxin X Severe acute respiratory disease syndrome-associated with a Coronavirus infection X X Coronavirus associated with severe acute respiratory disease X X X Shigellosis *4b X Shigella species *4b X Smallpox X X Variola virus (orthopox virus) X X X Staphylococcus aureus isolated from a normally sterile site Practitioner Reporting Not Applicable Staphylococcus aureus isolated from a normally sterile site *3 X Staphylococcus aureus with intermediate or full resistance to vancomycin (VISA,VRSA) X Staphylococcus aureus with intermediate or full resistance to vancomycin (VISA, VRSA); Laboratory results as specified in the surveillance case definition *4 X X Staphylococcus enterotoxin B X Staphylococcus enterotoxin B X X Streptococcus pneumoniae, invasive disease in children < 6 years, drug sensitive and resistant X Streptococcus pneumoniae, all ages, isolated from a normally sterile site *20 X Syphilis X Treponema pallidum X Syphilis in pregnant women and neonates X Treponema pallidum X Tetanus X Clostridium tetani X Trichinellosis (Trichinosis) X Trichinella spiralis X Tuberculosis (TB) *21 X Mycobacterium tuberculosis complex *21 X X Tularemia X X Francisella tularensis X X X Typhoid fever and paratyphoid fever *4b X Salmonella enterica serotype Typhi and Salmonella enterica serotypes Paratyphi A, Paratyphi B, and Paratyphi C *4b X X Typhus fever (epidemic) X X Rickettsia prowazekii X X X Vaccinia disease X X Vaccinia virus X X X Varicella (Chickenpox) *22 X Varicella virus X Varicella mortality X Varicella virus X Venezuelan equine encephalitis X X Venezuelan equine encephalitis virus X X X Vibriosis (infections by Vibrio species and closely related organisms, other than Cholera) X All non-cholera Vibrio species Photobacterium damselae, (formerly V. damsela); Grimontia hollisae (formerly V. hollisae) X X Viral hemorrhagic fevers X X Ebola, Marburg, Lassa, Machupo Lujo, new world Arena, or Congo-Crimean hemorrhagic fever viruses X X X West Nile virus (disease due to) X West Nile virus X X Yellow fever X X Yellow fever virus X X Zika fever *5 X Zika fever virus *5 X X *1 - Submission of isolates or specimens for confirmation to the Florida Department of Health, Bureau of Public Health Laboratories:     a. Each laboratory that obtains a human isolate or a specimen from a patient shall send isolates or specimens (such as sera, slides or diagnostic preparations) for confirmation or additional characterization of the organism.     b. Hospitals, practitioners and laboratories submitting specimens for reportable laboratory tests, pursuant to subsection 64D-3.031(3), F.A.C., are required to supply the laboratories with sufficient information to comply with the provisions of this section.     c. For the address of the closest Florida Department of Health laboratory location, contact: 1(866)352-5227.     d. Laboratories shall submit isolates or specimens for confirmation or additional characterization of the organism for any reportable disease listed in the Table of Reportable Diseases or Conditions to be Reported in this rule as requested by the Department.     e. Laboratories are not prohibited from submitting isolates or specimens from a patient for a disease or condition that is not designated in the Table of Reportable Diseases or Conditions to be Reported in this rule.     f. Submission should occur within two weeks from the time the isolate or specimen is received by the laboratory, unless otherwise noted by the Department. *2 - Include MIC (minimum inhibitory concentration), zone sizes for disk diffusion; MICs for E-test or agar dilution and interpretation (susceptible, intermediate, resistant). *3 - Paper reports are not required. Applies only to laboratories performing electronic laboratory reporting as described in subsection 64D-3.031(5), F.A.C. *4 - a. Surveillance Case Definitions for Select Reportable Diseases in Florida, 2016.